Skip to main content
. 2022 Oct 3;19(12):1762–1769. doi: 10.7150/ijms.76105

Table 3.

Differences in baseline characteristics of patients who with and without sICH

sICH (n = 34) Non-sICH (n = 472) p-value
Female (n, %) 15 (44.1%) 163 (34.5%) 0.258
Age (median, IQR), y 73 (68-80) 67 (58-74) <0.001
Current smoker (n, %) 7 (20.6%) 133 (28.2%) 0.339
Hypertension (n, %) 25 (73.5%) 317 (67.2%) 0.444
Hyperlipidemia (n, %) 7 (20.6%) 176 (37.3%) 0.05
Diabetes (n, %) 12 (35.3%) 100 (21.2%) 0.056
Chronic heart failure (n, %) 9 (26.5%) 86 (18.2%) 0.234
Atrial fibrillation (n, %) 25 (73.5%) 137 (29.0%) <0.001
Previous ischemic stroke (n, %) 4 (11.8%) 63 (13.3%) 0.999
Baseline SBP (mmHg, median, IQR) 142 (133-169) 149 (134-163) 0.573
Baseline blood glucose (mmol/L, median, IQR) 8.1 (6.5-11.6) 6.8 (5.9-8.3) 0.004
Baseline blood glucose ≥ 10mmol/L (n, %) 10 (29.4%) 67 (14.2%) 0.017
Baseline MCA hypertense sign (n, %)* 2 (6.3%) 24 (5.2%) 0.684
Type of occluded vessel (n, %) 0.203
Anterior 30 (88.2%) 355 (75.5%)
Posterior 0 45 (9.6%)
Mixed 3 (8.8%) 39 (8.3%)
Onset to thrombolysis time (min) 169 (123-210) 173 (120-210) 0.951
Baseline NIHSS score (median, IQR) 14 (9.5-17.5) 5 (3-11) <0.001
Low-dose (n, %) 2 (5.9%) 94 (19.9%) 0.074

Abbreviations: MCA, middle cerebral artery; NIHSS, national institute of health stroke scale; SBP, systolic blood pressure; sICH, symptomatic intracerebral hemorrhage;

*Data available in 490 patients;

Data available in 470 patients.